These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10143321)

  • 21. Cost-containment in mental health care: the role of utilization review.
    Dickey B; Azeni H
    Adv Health Econ Health Serv Res; 1993; 14():197-207. PubMed ID: 10164714
    [No Abstract]   [Full Text] [Related]  

  • 22. Is a target culture in health care always compatible with efficient use of resources? A cost-effectiveness analysis of an intervention to achieve thrombolysis targets.
    Singaroyan R; Seed CA; Egdell RM
    J Public Health (Oxf); 2006 Mar; 28(1):31-4. PubMed ID: 16436449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Challenges in economic outcomes research.
    Cook JR
    Hepatology; 1999 Jun; 29(6 Suppl):23S-25S. PubMed ID: 10386079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic evaluation of health programmes: application of the principles in developing countries.
    Mills A
    World Health Stat Q; 1985; 38(4):368-82. PubMed ID: 3938109
    [No Abstract]   [Full Text] [Related]  

  • 25. Theory and methods of economic evaluation of health care.
    Johannesson M
    Dev Health Econ Public Policy; 1996; 4():1-245. PubMed ID: 10158916
    [No Abstract]   [Full Text] [Related]  

  • 26. Industry anticipates big savings with new masks.
    AIDS Alert; 1995 Dec; 10(12):152-4. PubMed ID: 11362934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perspectives. New estimates credit managed care with savings, but upward pressures loom.
    Cunningham R
    Med Health; 1998 Sep; 52(37):suppl 1-4. PubMed ID: 10182925
    [No Abstract]   [Full Text] [Related]  

  • 28. Design and analysis issues for economic analysis alongside clinical trials.
    Marshall DA; Hux M
    Med Care; 2009 Jul; 47(7 Suppl 1):S14-20. PubMed ID: 19536012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue plasminogen activator was cost-effective compared to streptokinase in only selected patients with acute myocardial infarction.
    Kent DM; Vijan S; Hayward RA; Griffith JL; Beshansky JR; Selker HP
    J Clin Epidemiol; 2004 Aug; 57(8):843-52. PubMed ID: 15485737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measuring managed care: does it really save money?
    Grimaldi PL
    Healthc Financ Manage; 1988 Apr; 42(4):25-8, 30, 32. PubMed ID: 10312426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advancing the science of health care costing.
    Lipscomb J; Barnett PG; Brown ML; Lawrence W; Yabroff KR
    Med Care; 2009 Jul; 47(7 Suppl 1):S120-6. PubMed ID: 19536003
    [No Abstract]   [Full Text] [Related]  

  • 32. Directly observed treatment for multidrug-resistant tuberculosis: an economic evaluation in the United States of America and South Africa.
    Wilton P; Smith RD; Coast J; Millar M; Karcher A
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1137-42. PubMed ID: 11769772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Avalere health study conclusively proves home care is cost effective, saves billions for Medicare yearly, and effectively limits re-hospitalization.
    Dombi WA
    Caring; 2009 Jun; 28(6):22-3. PubMed ID: 19626962
    [No Abstract]   [Full Text] [Related]  

  • 34. [Resuscitation! Academic Medicine is in trouble].
    Pasternack A
    Duodecim; 2005; 121(16):1740-6. PubMed ID: 16268220
    [No Abstract]   [Full Text] [Related]  

  • 35. The estimated costs and savings of medical nutrition therapy: the Medicare population.
    Sheils JF; Rubin R; Stapleton DC
    J Am Diet Assoc; 1999 Apr; 99(4):428-35. PubMed ID: 10207394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Principles of economic evaluation of health programmes.
    Drumond MF; Stoddart GL
    World Health Stat Q; 1985; 38(4):355-67. PubMed ID: 3938108
    [No Abstract]   [Full Text] [Related]  

  • 37. Basic principles of cost-effectiveness analysis.
    Hillner BE
    Med Sect Proc; 1987; ():45-53. PubMed ID: 3133653
    [No Abstract]   [Full Text] [Related]  

  • 38. Editorial comment--stroke cost-effectiveness research: are acceptability curves acceptable?
    Holloway R; Dick AW
    Stroke; 2004 Jan; 35(1):203-4. PubMed ID: 14684768
    [No Abstract]   [Full Text] [Related]  

  • 39. Recommendations of the Second Panel on Cost Effectiveness in Health and Medicine: A Reference, Not a Rule Book.
    Carias C; Chesson HW; Grosse SD; Li R; Meltzer MI; Miller GF; Murphy LB; Nurmagambetov TA; Pike JJ; Whitham HK
    Am J Prev Med; 2018 Apr; 54(4):600-602. PubMed ID: 29338958
    [No Abstract]   [Full Text] [Related]  

  • 40. [Evaluation of the expenditures and cost benefit analysis of the tuberculosis control programs - methodological basis].
    Leowski K; Leowski J
    Pneumonol Pol; 1978 Nov; 46(11):757-64. PubMed ID: 101973
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.